Daniel E. Croker
Impact in
- Molecular Biology top 5%
- Inflammasome and immune disorders
- Receptor Mechanisms and Signaling
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Complement system in diseases 4
-
- Receptor Mechanisms and Signaling 4
- Chemical Synthesis and Analysis 4
- Inflammasome and immune disorders 2
- Co-authors
- Matthew A. Cooper (8 shared papers)Reena Halai (7 shared papers)Paul F. Alewood (5 shared papers)Geraldine Kaeslin (3 shared papers)Peter N. Monk (3 shared papers)David P. Fairlie (3 shared papers)Åsa Andersson (2 shared papers)Elka Palant (2 shared papers)
- Journals
- Immunology and Cell Biology (3 papers)Journal of Medicinal Chemistry (2 papers)Journal of Biological Chemistry (2 papers)Scientific Reports (1 paper)European Journal of Pharmacology (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Daniel E. Croker
14 papers receiving 2.8k citations
Daniel E. Croker's Hit Papers
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.8k
- Neurology 141
- Immunology 347
- Biological Psychiatry 15
- Nephrology 65
Countries citing papers authored by Daniel E. Croker
This map shows the geographic impact of Daniel E. Croker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Croker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Croker more than expected).
Fields of papers citing papers by Daniel E. Croker
This network shows the impact of papers produced by Daniel E. Croker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Croker. The network helps show where Daniel E. Croker may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel E. Croker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases Hit paper breakdown → | 2015 | 2362 |
| 2 | 2008 | 73 | |
| 3 | 2016 | 71 | |
| 4 | 2009 | 69 | |
| 5 | 2014 | 63 | |
| 6 | 2003 | 52 | |
| 7 | 2013 | 47 | |
| 8 | 2016 | 43 | |
| 9 | 2016 | 34 | |
| 10 | 2014 | 15 | |
| 11 | 2012 | 13 | |
| 12 | 2018 | 6 | |
| 13 | Discovery and pharmacology of conopressin-T, a novel vasopressin-like peptide from Conus tulipa. | 2006 | 2 |
| 14 | 2012 | 2 |
About Daniel E. Croker
Daniel E. Croker is a scholar working on Immunology, Molecular Biology, Cellular and Molecular Neuroscience, Genetics and Physiology, having authored 14 papers that have together received 2.9k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (4 papers), Chemical Synthesis and Analysis (4 papers), Complement system in diseases (4 papers), Venomous Animal Envenomation and Studies (3 papers), Neuropeptides and Animal Physiology (3 papers), Inflammasome and immune disorders (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Adipokines, Inflammation, and Metabolic Diseases (1 paper). The work is most often cited by research in Molecular Biology (1.8k citations), Neurology (141 citations), Immunology (347 citations), Biological Psychiatry (15 citations) and Nephrology (65 citations). Daniel E. Croker has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Matthew A. Cooper, Reena Halai, Paul F. Alewood, Geraldine Kaeslin, Peter N. Monk, David P. Fairlie, Åsa Andersson, Elka Palant, Richard James Lewis and Dianne Alewood. Their work appears in journals such as Immunology and Cell Biology, Journal of Medicinal Chemistry, Journal of Biological Chemistry, Scientific Reports and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.